Summa~% After i.v. injection in the rat, d-tubocurarine is taken up and concentrated by the liver. A method is developed for the visualisation of d-tubocurarine inside the liver cell by eleetron microscopy. Glutaraldehyde fixed liver blocks were immersed in an ammonium molybdate solution; d-tubocurarine was precipitated at sites of high concentration by molybdate, to form an insoluble d-tubocurarine-molybdate complex. This precipitate was found predominantly at the surface of lysosome-like particles, but also inside these organelles. In subeellular fraetionation experiments, d-tubocurarine was found with a high relative specific "activity" in the lysosomal fraction, lending support to a lysosomal tocalisation of d-tuboeurarine.
After i.v. administration many drugs are rapidly taken up in the liver of the rat and, subsequently, may be subject to biotransformation, stored in the liver, or excreted in bile. In this process, the concentration of the drug in the liver (moles/gram of liver) may become higher than the concentration in blood, as has been found for example with d-tuboeurarine (dTe) (Meijer et al., 1972) . This may be due to accumulation of this quaternary ammonium compound in, or at some subcellular particle. One of the main problems in the loealisation of drugs inside the intact liver cell is that in subcellular fractionation experiments many drugs, due to their high lipid solubility, are extensively bound to particles; this binding need not be related to the subeellular distribution of the drug in vivo, but may be due to the redistribution after homogenisation (unpublished results). Therefore we developed an electron microscopic method for visualisation of dTc inside the intact liver cell. Together with the outcome of the subcellular fractionation experiments, the present results suggest that the drug is concentrated in, or at the surface of liver lysosomes. Cohen et al. (1967) as modified by Meijer et al. (1972) . Subcellular Fractionation. Male rats (Wistar, about 300 g) had free access to food and water, since in previous experiments on the biliary excretion of dTc (YIeijer et al., 1972 ) also non-fasted had been used. The rats were anesthetised with pentobarbital (Nembutal| 60mg/kg) i.p. and the kidneys were ligated. A dose of 2.6 tzmoles dTc/kg (dissolved in 0.9~ w/v NaC1 in water), or saline alone (in the blanks) was injected into the vena jugularis externa. After 15 rain the liver was excised and put into icecold 0.15 M sucrose, pH 7.0. A 200/0 (w/v) homogenate was made using a Potter Elvehjem homogeniser. The subcellular fractions were prepared according to the method of De as described by Bouma and Gruber (1966) . In control experiments, animals received no dTc in vivo, but the amount of dTc, to be expected in the liver 15 rain after its i.v. injection, was added to the liver in the icecold homogenisation medium; the liver was subsequently homogenised in the presence of dTc.
Determinations. Acid phosphatase was determined according to Gianetto and de Dave (1955) . Protein was determined by the Lowry method, with bovine serum albumin as standard (Lowry et al., 1951) . 3H dTc was determined as described before (Meijer et al., 1972) .
Electron Microscopy o/ dTc in Rat Liver. Non-fasted rats were treated as described above. 15 rain after injection of the dTc solution or the saline, the liver was perfused through the portal vein with 1.5~ (w/v) glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for 2 rain at room temperature. The tissue was excised and small blocks were immersed for 1 hr in a l~ (w/v) solution of ammonium heptamolybdate in twice distilled water. The molybdate-dTc interaction resulted in a finely dispersed precipitate. Its visualisation was improved by keeping tissue contrast low. The tissue was therefore postfixed for only I hr in cacodylate buffered osmium tetroxide (1~ w/v) at 4 ~ C. Poststaining with metal salts was omitted for the same reason. The blocks were dehydrated in graded series of ethanol and in propylene oxide, and embedded in Epon 812. Ultra-thin sections were cut with a LKB Ultratome and examined unstained on unsupported grids in a Philips EM 300 electron microscope.
Results

Precipitation o[ d-Tubocurarine by Molybdate
In a pilot experiment we found that, out of a number of heavy metal salts, ammonium heptamolybdate most completely precipitated dTc from a solution in physiological saline in vitro. It seemed to form a complex, resulting in an insoluble white precipitate (Table 1) . The results from Table 1 suggest that more than one molecule of dTc complexes with each molecule of molybdate. Similar precipitates were obtained with ammonium metavanadate, dodeca tungsto-phosphoric acid (Hs[P(W3010)4]) and dodeea tungsto-silicic acid (H4[Si(W3010)4]). This complexing reaction of dTc with molybdate has also been described by Clarke (1969) .
Electron Microscopy o/ dTc in Rat Liver
To visualise dTc in the liver cell by electron microscopy we tried to use the precipitation reaction with molybdate in order to obtain an To a 2.5 mM solution of 3It dTe in physiological saline (pH 7.0) various amounts of ammonium heptamolybdafe were added, resulting in the final ammonium heptamolybdate concentrations given in the left column. The precipitate was spun down and after eentrifugation the percentage of 3tI remaining in the supernatant was determined. 100~ corresponds to about 300000 dpm/ml.
electron dense deposit at sites of a high dTe concentration. Liver tissue blocks of rats that had received dTe intravenously were treated with an ammonium molybdate solution (after fixation with glutaraldehyde). The electron micrographs (Figs. 1--3) show that in the dTc treated rats a precipitate can be found in association with particles that may be lysosomes. This precipitate is only found in the liver of dTc treated rats ; further, it is found only after molybdate treatment (Figs.4 and 5) . Therefore, we tentatively assume that the precipitate represents a dTe-mo]ybdate sediment at sites of high concentration of dTc in the liver cell. In the figures several typical examples of the dTe-molybdate precipitate are given. The results suggest that the precipitate is preferentially located at the membrane-surface of the particles, although it is found also inside the particles.
Subcellular Distribution o/aH dTe
In subcellular fractionation experiments we observed that 3H dTe, after i.v. administration, showed a distribution similar to that of acid phosphatase, a marker enzyme of the lysosomal fraction. Comparison of Fig.6A and 6B clearly shows that the accumulation of 3I-I dTc in the lysosomal fraction occurs only, if aH dTc is administered to the liver by the in vivo route (6A); when it was added to the liver homogenate in vitro, the dTc concentration in the lysosomal fraction was not enhanced but the compound was distributed nearly homogenously over all fractions (6B). About 16~ of the total amount present in the liver after 15 rain (0.09 ~xmoles) was found in the lysosomal fraction. Thus after i.v. injection, ~H dTe is (partly) associated with particulate matter sedi- • m e n t i n g in the ]ysosomal fraction. Of course, it cannot be concluded whether it is t a k e n up by a particle, p r e s u m a b l y a lysosome, or b o u n d to its surface.
Discussion
I n the present work a method is presented t h a t m a y become a tool in the s t u d y of the subcellular Iocalisation of drugs, dTc is precipitated in the form of an electron dense d T c -m o l y b d a t e complex. Although at present no data are available on the n a t u r e of this complex, it seems likely t h a t it is a n ion-pair formation between cationic dTc a n d anionic molybdate. The same reaction is used as identification reaction for dTc (Clarke, 1969) .
Results from subcellular fractionation are combined with electron microscopic evidence to suggest that dTc is, in part, bound to or taken up in lysosomes. It is unlikely, although it cannot be excluded completely, that the pertinent partieles might be fat droplets or mierobodies. In order to visuMise the dTc-molybdate precipitate, membrane contrast had to be kept low and consequently many membranes were poorly contrasted. Although this complicates the analysis of the electron micrographs, the results from the subcellular fractionation lend support to a lysosomal localisation of dTe after its in rive injection.
When dTe is added in vitro to the liver, a high affinity is found for binding to all particles (Fig. 6 ). This phenomenon masks the interactions with specific particles which take place when the drug is administered in rive. After homogenisation of the liver, the drug in the intact cell will be redistributed to an unknown extent, presumably in a manner similar to the distribution of dTc, when added in vitro. Nevertheless, a distinct increase in relative specific radioactivity of aH dTc in the lysosomal fraction is observed in the in vivo treated liver. The electron microscopical data show a localisation of dTc in lysosome-like particles. It is not yet clear why the dTc-molybdate complex is predominantly located at the outside of the particles, as is indicated in Figs. 1 --3 . One explanation for this type of location may be that dTe is primarily deposited at the outside when applied in vivo; alternatively, dTc may be distributed uniformly in the lysosome-like bodies and diffuse out of the particle during the incubation with molybdate which causes the complex to precipitate at the outside of the particles. This problem as well as the nature of the particles concerned require further investigation. The present results show that information can be obtained by an electron microscopical method on the subcellular distribution of dTc (and possibly other related cationic compounds) at a level which is inaccessible to conventional biochemical fractionation methods. The significance of the observed binding of dTc to lysosome-like bodies for handling of dTc by the liver remains to be investigated.
